Skip to search formSkip to main contentSkip to account menu

CD226 antigen

Known as: DNAX accessory molecule-1, PTA1 antigen, t lineage-specific activation antigen 1 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
In the present study, we report the analysis of NK cells derived from patients suffering from a rare ovarian cancer histotype of… 
Review
2015
Review
2015
Neuroblastoma (NBL) is an aggressive malignancy of the sympathetic nervous system (NS). Advanced stage neuroblastomas prove fatal… 
2014
2014
Background Rheumatoid arthritis (RA) is a frequent disease leading to joint destruction, deformity, and loss of function. Its… 
2014
2014
Background DNAM-1 (CD226) is well known as a genetic risk factor of many autoimmune diseases such as systemic sclerosis (SSc… 
Review
2012
Review
2012
Although tumor antigen-specific immunotherapy, such as dendritic cell vaccine, has recently emerged as a promising clinical… 
2011
2011
In a recent paper, Nabekura et al. (1) provided compelling evidence that abrogating DNAM-1 (DNAX accessory molecule-1; CD226… 
2005
2005
Purpose: Chromosome 18q deletion has been described as a negative prognostic factor in colorectal cancer (CRC). The relationship…